Eurobio-Scientific SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013240934
EUR
22.15
22.15 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
EssilorLuxottica SA
Guerbet SA
bioMérieux SA
Sartorius Stedim Biotech SA
Amplitude Surgical SAS
Eurobio-Scientific SA
Nanobiotix SA
Crossject SA
Pixium Vision SA
Visiomed Group SA
Biosynex SA

Why is Eurobio-Scientific SA ?

1
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at EUR 32.61 MM
  • ROCE(HY) Lowest at 1.32%
2
With ROE of 3.30%, it has a Very Expensive valuation with a 1.33 Price to Book Value
  • Over the past year, while the stock has generated a return of -13.65%, its profits have fallen by -21.8%
3
Underperformed the market in the last 1 year
  • Even though the market (France CAC 40) generated negative returns of -1.81% in the last 1 year, its fall in the stock was much higher with a return of -13.65%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
-2.69%
EBIT to Interest (avg)
37.35
Debt to EBITDA (avg)
0.21
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.87
Tax Ratio
36.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
50.52%
ROE (avg)
25.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
1.33
EV to EBIT
15.57
EV to EBITDA
7.76
EV to Capital Employed
1.35
EV to Sales
1.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.69%
ROE (Latest)
3.30%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -11.48% (YoY

-5What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at EUR 32.61 MM

ROCE(HY)

Lowest at 1.32%

Here's what is working for Eurobio-Scientific SA

Raw Material Cost
Fallen by -11.48% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Eurobio-Scientific SA

Operating Cash Flow
Lowest at EUR 32.61 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (EUR MM)